|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Otsubo T, Yamada K, Hagiwara T, Oshima K,
Iida K, Nishikata K, Toyoda T, Igari T, Nohara K, Yamashita S, et
al: DNA hypermethyation and silencing of PITX1 correlated with
advanced stage and poor postoperative prognosis of esophageal
squamous cell carcinoma. Oncotarget. 8:84434–84448. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shaheen O, Ghibour A and Alsaid B:
Esophageal cancer metastases to unexpected site: A systematic
review. Gastroenterol Res Pract. 2017:16573102017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Luo Y, Mao Q, Wang X, Yu J and Li M:
Radiotherapy for esophageal carcinoma: Dose, response and survival.
Cancer Manag Res. 10:13–21. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu SG, Zhang WW, He ZY, Sun JY, Chen YX
and Guo L: Sites of metastasis and overall survival in esophageal
cancer: A population-based study. Cancer Manag Res. 9:781–788.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Harada K, Baba Y, Ishimoto T, Shigaki H,
Kosumi K, Yoshida N, Watanabe M and Baba H: The role of microRNA in
esophageal squamous cell carcinoma. J Gastroenterol. 51:520–530.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wan TM, Lam CS, Nq L, Chow AK, Wong SK, Li
HS, Man JH, Lo OS, Foo D, Cheung A, et al: The clinicopathological
significance of miR-133a in colorectal cancer. Dis Markers.
2014:9192832014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schickel R, Boyerinas B, Park SM and Peter
ME: MicroRNAs: Key players in the immune system, differentiation,
tumorigenesis and cell death. Oncogene. 27:5959–5974. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
El-Daly SM, Abba ML and Gamal-Eldeen AM:
The role of microRNAs in photodynmic therapy of cancer. Eur J Med
Chem. 142:550–555. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao L, Shan B, Du Y, Wang M, Liu L and
Ren FZ: Periplocin from Cortex periplocae inhibits cell growth and
down-regulates survivin and c-myc expression in colon cancer in
vitro and in vivo via beta-catenin/TCF signaling. Oncol Rep.
24:375–383. 2010.PubMed/NCBI
|
|
13
|
Yong-Ming H, Ai-Jun J, Xiao-Yue X,
Jian-Wei L, Chen Y and Ye C: miR-449a: A potential therapeutic
agent for cancer. Anticancer Drugs. 28:1067–1078. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu JF, Wang QZ and Hou J: Surgical
treatment for cancer of the esophagus and gastric cardia in Hebei,
China. Br J Surg. 91:90–98. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stoner GD and Wang LS: Chemoprevention of
esophageal squamous cell carcinoma with berries. Top Curr Chem.
329:1–20. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mei LL, Qiu YT, Zhang B and Shi ZZ:
MicroRNAs in esophageal squamous cell carcinoma: Potential
biomarkers and therapeutic targets. Cancer Biomark. 19:1–9. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wei W, Hu Z, Fu H, Tie Y, Zhang H, Wu Y
and Zheng X: MicroRNA-1 and microRNA-499 downregulate the
expression of the ets1 proto-oncogene in HepG2 cells. Oncol Rep.
28:701–706. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Voorhoeve PM, le Sage C, Schrier M, Gillis
AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A,
et al: A genetic screen implicates miRNA-372 and miRNA-373 as
oncogenes in testicular germ cell tumors. Cell. 124:1169–1181.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Detassis S, Grasso M, Del Vescovo V and
Denti MA: MicroRNAs make the call in cancer personalized medicine.
Front Cell Dev Biol. 5:862017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack
FJ: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
O'Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: C-Myc regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Langevin SM and Christensen BC: Let-7
microRNA-binding-site polymorphism in the 3′UTR of KRAS and
colorectal cancer outcome: A systematic review and meta-analysis.
Cancer Med. 3:1385–1395. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pekarsky Y, Balatti V and Croce CM: BCL2
and miR-15/16: From gene discovery to treatment. Cell Death Differ.
25:21–26. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Noonan EJ, Place RF, Pookot D, Basak S,
Whitson JM, Hirata H, Giardina C and Dahiya R: miR-449a targets
HDAC-1 and induces growth arrest in prostate cancer. Oncogene.
28:1714–1724. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kheir Bou T, Futoma-Kazmierczak E,
Jacobsen A, Krogh A, Bardram L, Hother C, Grønbæk K, Federspiel B,
Lund AH and Friis-Hansen L: miR-449 inhibits cell proliferation and
is down-regulated in gastric cancer. Mol Cancer. 10:292011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen H, Lin YW, Mao YQ, Wu J, Liu YF,
Zheng XY and Xie LP: MicroRNA-449a acts as a tumor suppressor in
human bladder cancer through the regulation of pocket proteins.
Cancer Lett. 320:40–47. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jeon HS, Lee SY, Lee EJ, Yun SC, Cha EJ,
Choi E, Na MJ, Park JY, Kang J and Son JW: Combining
microRNA-449a/b with a HDAC inhibitor has a synergistic effect on
growth arrest in lung cancer. Lung Cancer. 76:171–176. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang X, Feng M, Jiang X, Wu Z, Li Z, Aau M
and Yu Q: MiR-449a and miR-449b are direct transcriptional targets
of E2F1 and negatively regulate pRb-E2F1 activity through a
feedback loop by targeting CDK6 and CDC25A. Genes Dev.
23:2388–2393. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lizé M, Pilarski S and Dobbelstein M:
E2F1-inducible microRNA 449a/b suppresses cell proliferation and
promotes apoptosis. Cell Death Differ. 17:452–458. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Feng M and Yu Q: miR-449 regulates
CDK-Rb-E2F1 through an auto-regulatory feedback circuit. Cell
Cycle. 9:213–214. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Noonan EJ, Place RF, Basak S, Pookot D and
Li LC: miR-449a causes Rb-dependent cell cycle arrest and
senescence in prostate cancer cells. Oncotarget. 1:349–358.
2010.PubMed/NCBI
|
|
35
|
Ni Y, Meng L, Wang L, Dong W, Shen H, Wang
G, Liu Q and Du J: MicroRNA-143 functions as a tumor suppressor in
human esophageal squamous cell carcinoma. Gene. 517:197–204. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Felekkis K, Touvana E, Stefanou Ch and
Deltas C: microRNAs: A newly described class of encoded molecules
that play a role in health and disease. Hippokratia. 14:236–240.
2010.PubMed/NCBI
|
